377220 — From Bio Co Income Statement
0.000.00%
Last trade - 00:00- KR₩34bn
- KR₩65bn
- KR₩72bn
Annual income statement for From Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 135,103 | 99,330 | 66,724 | 67,182 | 72,162 |
| Cost of Revenue | |||||
| Gross Profit | 102,104 | 69,309 | 45,955 | 37,145 | 41,551 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 123,762 | 98,533 | 82,239 | 91,595 | 91,197 |
| Operating Profit | 11,341 | 797 | -15,515 | -24,413 | -19,035 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 11,638 | 1,512 | -15,740 | -24,892 | -20,878 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 11,282 | 1,318 | -11,609 | -26,230 | -23,203 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 11,282 | 3,241 | -11,076 | -25,288 | -22,457 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 11,282 | 3,241 | -11,076 | -25,288 | -22,457 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 464 | 118 | -389 | -898 | -792 |
| Dividends per Share |